Search details
1.
Therapeutic evaluation of immunomodulators in reducing surgical wound infection.
FASEB J
; 36(1): e22090, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34907595
2.
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
Proc Natl Acad Sci U S A
; 117(2): 1119-1128, 2020 01 14.
Article
in English
| MEDLINE | ID: mdl-31888983
3.
Pseudomonas aeruginosa ExoT induces G1 cell cycle arrest in melanoma cells.
Cell Microbiol
; 23(8): e13339, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33821556
4.
A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
Oncologist
; 26(10): 811-817, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34018286
5.
Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression.
J Immunol
; 201(11): 3456-3464, 2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30373846
6.
Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer.
Int J Mol Sci
; 21(20)2020 Oct 16.
Article
in English
| MEDLINE | ID: mdl-33081107
7.
Sebaceous carcinoma: evidence-based clinical practice guidelines.
Lancet Oncol
; 20(12): e699-e714, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31797796
8.
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.
J Immunol
; 198(3): 1365-1375, 2017 02 01.
Article
in English
| MEDLINE | ID: mdl-28011934
9.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Cancer
; 124(22): 4332-4341, 2018 11 15.
Article
in English
| MEDLINE | ID: mdl-30303516
10.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Lancet
; 390(10094): 555-566, 2017 08 05.
Article
in English
| MEDLINE | ID: mdl-28600132
11.
Minimum thresholds deemed acceptable by patients and physicians for sensitivity and specificity of mobile skin cancer screening algorithms.
J Am Acad Dermatol
; 89(3): 595-597, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37187429
12.
Targeting Ornithine Decarboxylase by α-Difluoromethylornithine Inhibits Tumor Growth by Impairing Myeloid-Derived Suppressor Cells.
J Immunol
; 196(2): 915-23, 2016 Jan 15.
Article
in English
| MEDLINE | ID: mdl-26663722
13.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Article
in English
| MEDLINE | ID: mdl-28334439
14.
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
; 387(10032): 2008-16, 2016 May 14.
Article
in English
| MEDLINE | ID: mdl-26969090
15.
National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.
Ann Surg Oncol
; 23(11): 3548-3557, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27278202
16.
Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome.
Blood
; 123(8): 1159-66, 2014 Feb 20.
Article
in English
| MEDLINE | ID: mdl-24335103
17.
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.
J Natl Compr Canc Netw
; 14(10): 1213-1224, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27697976
18.
Testicular Cancer, Version 2.2015.
J Natl Compr Canc Netw
; 13(6): 772-99, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-26085393
19.
Kidney cancer, version 3.2015.
J Natl Compr Canc Netw
; 13(2): 151-9, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25691606
20.
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
N Engl J Med
; 364(22): 2119-27, 2011 Jun 02.
Article
in English
| MEDLINE | ID: mdl-21631324